SolasCure Limited announced that it has received £10.9 million in a round of funding led by returning investor Seneca Partners Limited on March 27, 2023. The transaction also included participation from Wealth Club Limited, returning investors BRAIN Biotech AG, Eva Pharma Consultants Ltd and Jonathan Milner.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.79 EUR | +0.36% | -7.00% | -23.77% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.77% | 64.99M | |
-29.36% | 216M | |
+18.89% | 59.59M |
- Stock Market
- Equities
- BNN Stock
- News BRAIN Biotech AG
- SolasCure Limited announced that it has received £10.9 million in funding from Seneca Partners Limited, BRAIN Biotech AG, Eva Pharma Consultants Ltd, Wealth Club Limited and another investor